{"id":"https://openalex.org/W2917655435","doi":"https://doi.org/10.1136/gutjnl-2019-318269","title":"Messenger RNA therapy for rare genetic metabolic diseases","display_name":"Messenger RNA therapy for rare genetic metabolic diseases","alternate_titles":[],"publication_year":2019,"publication_date":"2019-02-22","ids":{"openalex":"https://openalex.org/W2917655435","doi":"https://doi.org/10.1136/gutjnl-2019-318269","mag":"2917655435","pmid":"https://pubmed.ncbi.nlm.nih.gov/30796097"},"language":"en","primary_location":{"id":"doi:10.1136/gutjnl-2019-318269","doi":"https://doi.org/10.1136/gutjnl-2019-318269","is_oa":true,"landing_page_url":"https://doi.org/10.1136/gutjnl-2019-318269","pdf_url":"https://gut.bmj.com/content/gutjnl/68/7/1323.full.pdf","source":{"id":"https://openalex.org/S3251770","display_name":"Gut","issn_l":"0017-5749","issn":["0017-5749","1468-3288"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Gut","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2917655435"],"child_works_count":0,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://gut.bmj.com/content/gutjnl/68/7/1323.full.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5064978271","display_name":"Pedro Berraondo","orcid":"https://orcid.org/0000-0001-7410-1865","observed_orcids":["https://orcid.org/0000-0001-7410-1865"]},"institutions":[{"id":"https://openalex.org/I2801357902","display_name":"Instituto de Salud Carlos III","ror":"https://ror.org/00ca2c886","country_code":"ES","type":"nonprofit","lineage":["https://openalex.org/I2801357902","https://openalex.org/I4387152914"]},{"id":"https://openalex.org/I4210112085","display_name":"Navarre Institute of Health Research","ror":"https://ror.org/023d5h353","country_code":"ES","type":"education","lineage":["https://openalex.org/I4210112085"]},{"id":"https://openalex.org/I4210158561","display_name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de C\u00e1ncer","ror":"https://ror.org/04hya7017","country_code":"ES","type":"facility","lineage":["https://openalex.org/I4210158561"]},{"id":"https://openalex.org/I4392738196","display_name":"Centro de Investigaci\u00f3n M\u00e9dica Aplicada","ror":"https://ror.org/01qew8q20","country_code":"ES","type":"nonprofit","lineage":["https://openalex.org/I4392738196","https://openalex.org/I88155538"]},{"id":"https://openalex.org/I88155538","display_name":"Universidad de Navarra","ror":"https://ror.org/02rxc7m23","country_code":"ES","type":"education","lineage":["https://openalex.org/I88155538"]}],"countries":["ES"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Pedro Berraondo","raw_affiliation_strings":["Centro de Investigaci\u00f3n Biom\u00e9dica en Red de C\u00e1ncer, CIBERonc, Instituto de Salud Carlos III, Madrid, Spain","Immunology and Immunotherapy Program, Centro de Investigaci\u00f3n M\u00e9dica Aplicada (Cima), University of Navarra, Pamplona, Navarra, Spain","Instituto de Investigaci\u00f3n Sanitaria de Navarra IdiSNA, Pamplona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de C\u00e1ncer, CIBERonc, Instituto de Salud Carlos III, Madrid, Spain","institution_ids":["https://openalex.org/I2801357902","https://openalex.org/I4210158561"]},{"raw_affiliation_string":"Immunology and Immunotherapy Program, Centro de Investigaci\u00f3n M\u00e9dica Aplicada (Cima), University of Navarra, Pamplona, Navarra, Spain","institution_ids":["https://openalex.org/I4392738196","https://openalex.org/I88155538"]},{"raw_affiliation_string":"Instituto de Investigaci\u00f3n Sanitaria de Navarra IdiSNA, Pamplona, Spain","institution_ids":["https://openalex.org/I4210112085"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043654363","display_name":"Paolo G.V. Martini","orcid":"https://orcid.org/0000-0002-0051-797X","observed_orcids":["https://orcid.org/0000-0002-0051-797X"]},"institutions":[{"id":"https://openalex.org/I4210108601","display_name":"Moderna Therapeutics (United States)","ror":"https://ror.org/01xm4wg91","country_code":"US","type":"company","lineage":["https://openalex.org/I4210108601"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Paolo G V Martini","raw_affiliation_strings":["Moderna Therapeutics, Cambridge, Massachusetts, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Moderna Therapeutics, Cambridge, Massachusetts, USA","institution_ids":["https://openalex.org/I4210108601"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016683081","display_name":"Matias Antonio Avila","orcid":"https://orcid.org/0000-0001-6570-3557","observed_orcids":["https://orcid.org/0000-0001-6570-3557"]},"institutions":[{"id":"https://openalex.org/I2801357902","display_name":"Instituto de Salud Carlos III","ror":"https://ror.org/00ca2c886","country_code":"ES","type":"nonprofit","lineage":["https://openalex.org/I2801357902","https://openalex.org/I4387152914"]},{"id":"https://openalex.org/I4210112085","display_name":"Navarre Institute of Health Research","ror":"https://ror.org/023d5h353","country_code":"ES","type":"education","lineage":["https://openalex.org/I4210112085"]},{"id":"https://openalex.org/I4210132431","display_name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Hep\u00e1ticas y Digestivas","ror":"https://ror.org/03cn6tr16","country_code":"ES","type":"facility","lineage":["https://openalex.org/I4210132431"]},{"id":"https://openalex.org/I4392738196","display_name":"Centro de Investigaci\u00f3n M\u00e9dica Aplicada","ror":"https://ror.org/01qew8q20","country_code":"ES","type":"nonprofit","lineage":["https://openalex.org/I4392738196","https://openalex.org/I88155538"]},{"id":"https://openalex.org/I88155538","display_name":"Universidad de Navarra","ror":"https://ror.org/02rxc7m23","country_code":"ES","type":"education","lineage":["https://openalex.org/I88155538"]}],"countries":["ES"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Matias A Avila","raw_affiliation_strings":["Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Hep\u00e1ticas y Digestivas, CIBERehd, Instituto de Salud Carlos III, Madrid, Spain","Hepatology Program, CIMA, University of Navarra, Pamplona, Navarra, Spain","Instituto de Investigaci\u00f3n Sanitaria de Navarra IdiSNA, Pamplona, Spain","Hepatology Program, CIMA, University of Navarra, Pamplona, Navarra 31008, Spain"],"raw_orcid":"https://orcid.org/0000-0001-6570-3557","affiliations":[{"raw_affiliation_string":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Hep\u00e1ticas y Digestivas, CIBERehd, Instituto de Salud Carlos III, Madrid, Spain","institution_ids":["https://openalex.org/I2801357902","https://openalex.org/I4210132431"]},{"raw_affiliation_string":"Hepatology Program, CIMA, University of Navarra, Pamplona, Navarra, Spain","institution_ids":["https://openalex.org/I4392738196","https://openalex.org/I88155538"]},{"raw_affiliation_string":"Instituto de Investigaci\u00f3n Sanitaria de Navarra IdiSNA, Pamplona, Spain","institution_ids":["https://openalex.org/I4210112085"]},{"raw_affiliation_string":"Hepatology Program, CIMA, University of Navarra, Pamplona, Navarra 31008, Spain","institution_ids":["https://openalex.org/I4392738196","https://openalex.org/I88155538"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5077733484","display_name":"Antonio Fontanellas","orcid":"https://orcid.org/0000-0001-9279-7990","observed_orcids":["https://orcid.org/0000-0001-9279-7990"]},"institutions":[{"id":"https://openalex.org/I2801357902","display_name":"Instituto de Salud Carlos III","ror":"https://ror.org/00ca2c886","country_code":"ES","type":"nonprofit","lineage":["https://openalex.org/I2801357902","https://openalex.org/I4387152914"]},{"id":"https://openalex.org/I4210112085","display_name":"Navarre Institute of Health Research","ror":"https://ror.org/023d5h353","country_code":"ES","type":"education","lineage":["https://openalex.org/I4210112085"]},{"id":"https://openalex.org/I4210132431","display_name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Hep\u00e1ticas y Digestivas","ror":"https://ror.org/03cn6tr16","country_code":"ES","type":"facility","lineage":["https://openalex.org/I4210132431"]},{"id":"https://openalex.org/I4392738196","display_name":"Centro de Investigaci\u00f3n M\u00e9dica Aplicada","ror":"https://ror.org/01qew8q20","country_code":"ES","type":"nonprofit","lineage":["https://openalex.org/I4392738196","https://openalex.org/I88155538"]},{"id":"https://openalex.org/I88155538","display_name":"Universidad de Navarra","ror":"https://ror.org/02rxc7m23","country_code":"ES","type":"education","lineage":["https://openalex.org/I88155538"]}],"countries":["ES"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Antonio Fontanellas","raw_affiliation_strings":["Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Hep\u00e1ticas y Digestivas, CIBERehd, Instituto de Salud Carlos III, Madrid, Spain","Hepatology Program, CIMA, University of Navarra, Pamplona, Navarra, Spain","Instituto de Investigaci\u00f3n Sanitaria de Navarra IdiSNA, Pamplona, Spain","Hepatology Program, CIMA, University of Navarra, Pamplona, Navarra 31008, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Hep\u00e1ticas y Digestivas, CIBERehd, Instituto de Salud Carlos III, Madrid, Spain","institution_ids":["https://openalex.org/I2801357902","https://openalex.org/I4210132431"]},{"raw_affiliation_string":"Hepatology Program, CIMA, University of Navarra, Pamplona, Navarra, Spain","institution_ids":["https://openalex.org/I4392738196","https://openalex.org/I88155538"]},{"raw_affiliation_string":"Instituto de Investigaci\u00f3n Sanitaria de Navarra IdiSNA, Pamplona, Spain","institution_ids":["https://openalex.org/I4210112085"]},{"raw_affiliation_string":"Hepatology Program, CIMA, University of Navarra, Pamplona, Navarra 31008, Spain","institution_ids":["https://openalex.org/I4392738196","https://openalex.org/I88155538"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":7,"corresponding_author_ids":["https://openalex.org/A5016683081","https://openalex.org/A5077733484"],"corresponding_institution_ids":["https://openalex.org/I2801357902","https://openalex.org/I4210112085","https://openalex.org/I4210132431","https://openalex.org/I4392738196","https://openalex.org/I88155538"],"apc_list":null,"apc_paid":null,"fwci":1.1136,"has_fulltext":true,"cited_by_count":131,"citation_normalized_percentile":{"value":0.75744179,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":99,"max":100},"biblio":{"volume":"68","issue":"7","first_page":"1323","last_page":"1330"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10725","display_name":"RNA Interference and Gene Delivery","score":0.9312000274658203,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10725","display_name":"RNA Interference and Gene Delivery","score":0.9312000274658203,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11027","display_name":"Metabolism and Genetic Disorders","score":0.03550000116229057,"subfield":{"id":"https://openalex.org/subfields/1308","display_name":"Clinical Biochemistry"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10945","display_name":"Lysosomal Storage Disorders Research","score":0.006099999882280827,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/mrna-therapeutics","display_name":"mRNA therapeutics","score":0.7480000257492065},{"id":"https://openalex.org/keywords/protein-replacement-therapy","display_name":"protein replacement therapy","score":0.8640000224113464},{"id":"https://openalex.org/keywords/lipid-nanoparticles","display_name":"lipid nanoparticles","score":0.8040000200271606},{"id":"https://openalex.org/keywords/methylmalonic-acidemia","display_name":"methylmalonic acidemia","score":0.9300000071525574},{"id":"https://openalex.org/keywords/acute-intermittent-porphyria","display_name":"acute intermittent porphyria","score":0.9980000257492065},{"id":"https://openalex.org/keywords/ornithine-transcarbamylase-deficiency","display_name":"ornithine transcarbamylase deficiency","score":0.9940000176429749},{"id":"https://openalex.org/keywords/immunogenicity-reduction","display_name":"immunogenicity reduction","score":0.6650000214576721}],"concepts":[{"id":"https://openalex.org/C105580179","wikidata":"https://www.wikidata.org/wiki/Q188928","display_name":"Messenger RNA","level":3,"score":0.5925365090370178},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.5198709964752197},{"id":"https://openalex.org/C2780469793","wikidata":"https://www.wikidata.org/wiki/Q3043161","display_name":"Ornithine transcarbamylase deficiency","level":5,"score":0.4511019289493561},{"id":"https://openalex.org/C2780868878","wikidata":"https://www.wikidata.org/wiki/Q1660197","display_name":"Immunogenicity","level":3,"score":0.4364134967327118},{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.4027971923351288},{"id":"https://openalex.org/C60644358","wikidata":"https://www.wikidata.org/wiki/Q128570","display_name":"Bioinformatics","level":1,"score":0.3820685148239136},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3335261344909668},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.2748924493789673},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.24146652221679688},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.22254282236099243},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.16720405220985413},{"id":"https://openalex.org/C77061444","wikidata":"https://www.wikidata.org/wiki/Q595994","display_name":"Urea cycle","level":4,"score":0.15268534421920776},{"id":"https://openalex.org/C515207424","wikidata":"https://www.wikidata.org/wiki/Q8066","display_name":"Amino acid","level":2,"score":0.0},{"id":"https://openalex.org/C2777468819","wikidata":"https://www.wikidata.org/wiki/Q173670","display_name":"Arginine","level":3,"score":0.0}],"mesh":[{"descriptor_ui":"D000592","descriptor_name":"Amino Acid Metabolism, Inborn Errors","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007167","descriptor_name":"Immunotherapy","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D012333","descriptor_name":"RNA, Messenger","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D017118","descriptor_name":"Porphyria, Acute Intermittent","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true},{"descriptor_ui":"D020163","descriptor_name":"Ornithine Carbamoyltransferase Deficiency Disease","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true},{"descriptor_ui":"D035583","descriptor_name":"Rare Diseases","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1136/gutjnl-2019-318269","doi":"https://doi.org/10.1136/gutjnl-2019-318269","is_oa":true,"landing_page_url":"https://doi.org/10.1136/gutjnl-2019-318269","pdf_url":"https://gut.bmj.com/content/gutjnl/68/7/1323.full.pdf","source":{"id":"https://openalex.org/S3251770","display_name":"Gut","issn_l":"0017-5749","issn":["0017-5749","1468-3288"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Gut","raw_type":"journal-article"},{"id":"pmid:30796097","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/30796097","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Gut","raw_type":"Journal Article"},{"id":"pmh:oai:dadun.unav.edu:10171/68667","doi":null,"is_oa":true,"landing_page_url":"https://hdl.handle.net/10171/68667","pdf_url":"https://dadun.unav.edu/bitstreams/9b2f257a-2a41-4c55-b70b-7c14e379546c/download","source":{"id":"https://openalex.org/S4306401514","display_name":"Dep\u00f3sito Acad\u00e9mico Digital Universidad de Navarra (University of Navarra)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I88155538","host_organization_name":"Universidad de Navarra","host_organization_lineage":["https://openalex.org/I88155538"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:open-archive.highwire.org:gutjnl:68/7/1323","doi":null,"is_oa":false,"landing_page_url":"http://gut.bmj.com/cgi/content/short/68/7/1323","pdf_url":null,"source":{"id":"https://openalex.org/S4406923041","display_name":"HighWire Press Open Archive","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"TEXT"}],"best_oa_location":{"id":"doi:10.1136/gutjnl-2019-318269","doi":"https://doi.org/10.1136/gutjnl-2019-318269","is_oa":true,"landing_page_url":"https://doi.org/10.1136/gutjnl-2019-318269","pdf_url":"https://gut.bmj.com/content/gutjnl/68/7/1323.full.pdf","source":{"id":"https://openalex.org/S3251770","display_name":"Gut","issn_l":"0017-5749","issn":["0017-5749","1468-3288"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Gut","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9537000060081482,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G1314305536","display_name":"Explotando SR-B1 para el desarrollo de nuevos f\u00e1rmacos inmunomodulares para potenciar la inmunoterapia del c\u00e1ncer","funder_award_id":"PI16/00668","funder_id":"https://openalex.org/F4320334923","funder_display_name":"Instituto de Salud Carlos III"},{"id":"https://openalex.org/G2250445770","display_name":"Ensayo precl\u00ednico del conjugado Apo AI con porfobilin\u00f3geno desaminasa para el tratamiento precoz de crisis agudas de porfiria. Validaci\u00f3n de VDBP urinaria como biomarcador predictivo","funder_award_id":"PI15/01951","funder_id":"https://openalex.org/F4320334923","funder_display_name":"Instituto de Salud Carlos III"},{"id":"https://openalex.org/G748679504","display_name":"Ensayo precl\u00ednico con ARN mensajero para el tratamiento etiol\u00f3gico de la porfiria aguda intermitente. Eficacia y seguridad en primates no humanos y en un nuevo modelo de porfiria hep\u00e1tica en conejo .","funder_award_id":"PI18/00860","funder_id":"https://openalex.org/F4320334923","funder_display_name":"Instituto de Salud Carlos III"},{"id":"https://openalex.org/G7716198301","display_name":null,"funder_award_id":"CPII15/00004","funder_id":"https://openalex.org/F4320334923","funder_display_name":"Instituto de Salud Carlos III"}],"funders":[{"id":"https://openalex.org/F4320310215","display_name":"Fundaci\u00f3n Eugenio Rodr\u00edguez Pascual","ror":"https://ror.org/03p40sz62"},{"id":"https://openalex.org/F4320310220","display_name":"Fundaci\u00f3n Mutua Madrile\u00f1a","ror":"https://ror.org/00skv9577"},{"id":"https://openalex.org/F4320322649","display_name":"Universidad de Navarra","ror":"https://ror.org/02rxc7m23"},{"id":"https://openalex.org/F4320327235","display_name":"Servier","ror":"https://ror.org/034e7c066"},{"id":"https://openalex.org/F4320334923","display_name":"Instituto de Salud Carlos III","ror":"https://ror.org/00ca2c886"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2917655435.pdf","grobid_xml":"https://content.openalex.org/works/W2917655435.grobid-xml"},"referenced_works_count":68,"referenced_works":["https://openalex.org/W50060077","https://openalex.org/W1518729035","https://openalex.org/W1562624167","https://openalex.org/W1566010314","https://openalex.org/W1649073302","https://openalex.org/W1838293083","https://openalex.org/W1903214678","https://openalex.org/W1963706689","https://openalex.org/W1968376422","https://openalex.org/W1980420887","https://openalex.org/W1987632740","https://openalex.org/W1990508860","https://openalex.org/W1991438029","https://openalex.org/W2018656452","https://openalex.org/W2019868085","https://openalex.org/W2031457189","https://openalex.org/W2034973225","https://openalex.org/W2039064708","https://openalex.org/W2041572378","https://openalex.org/W2042768109","https://openalex.org/W2044487970","https://openalex.org/W2045383988","https://openalex.org/W2053110265","https://openalex.org/W2058647478","https://openalex.org/W2058827735","https://openalex.org/W2059267377","https://openalex.org/W2059924653","https://openalex.org/W2067245014","https://openalex.org/W2069360361","https://openalex.org/W2081306620","https://openalex.org/W2093424805","https://openalex.org/W2109274792","https://openalex.org/W2122304523","https://openalex.org/W2130011407","https://openalex.org/W2137222303","https://openalex.org/W2143743183","https://openalex.org/W2145301070","https://openalex.org/W2167179149","https://openalex.org/W2214097311","https://openalex.org/W2253584908","https://openalex.org/W2398306036","https://openalex.org/W2402482204","https://openalex.org/W2404919825","https://openalex.org/W2474379397","https://openalex.org/W2521934085","https://openalex.org/W2523883354","https://openalex.org/W2528381283","https://openalex.org/W2546860491","https://openalex.org/W2564053957","https://openalex.org/W2587871737","https://openalex.org/W2606493012","https://openalex.org/W2748490245","https://openalex.org/W2777634859","https://openalex.org/W2782155349","https://openalex.org/W2789915301","https://openalex.org/W2791512052","https://openalex.org/W2791854174","https://openalex.org/W2801321266","https://openalex.org/W2889813782","https://openalex.org/W2894600652","https://openalex.org/W2895539268","https://openalex.org/W2896051729","https://openalex.org/W2964061133","https://openalex.org/W2988590615","https://openalex.org/W2990322947","https://openalex.org/W2998094044","https://openalex.org/W3007555013","https://openalex.org/W4253599714"],"related_works":["https://openalex.org/W4285252568","https://openalex.org/W2952719558","https://openalex.org/W4416971996","https://openalex.org/W4404200097","https://openalex.org/W2973550391","https://openalex.org/W4397003327","https://openalex.org/W4408993839","https://openalex.org/W7155156633","https://openalex.org/W4394992359","https://openalex.org/W4401344755"],"abstract_inverted_index":{"Decades":[0],"of":[1,14,23,60,113,118,157,167],"intense":[2],"research":[3],"in":[4,11,69,94,128],"molecular":[5],"biology":[6],"and":[7,44,62,71,96,105,131,159,181],"biochemistry":[8],"are":[9,90,121,125],"fructifying":[10],"the":[12,58,78,116,161,165],"emergence":[13],"therapeutic":[15],"messenger":[16],"RNAs":[17],"(mRNA)":[18],"as":[19,36,38],"a":[20,129,141],"new":[21,155],"class":[22,156],"drugs.":[24],"Synthetic":[25],"mRNAs":[26,84,114],"can":[27],"be":[28],"sequence":[29],"optimised":[30],"to":[31,41],"improve":[32],"translatability":[33],"into":[34,86],"proteins,":[35],"well":[37],"chemically":[39],"modified":[40],"reduce":[42],"immunogenicity":[43],"increase":[45],"chemical":[46],"stability":[47],"using":[48],"naturally":[49],"occurring":[50],"uridine":[51],"modifications.":[52],"These":[53],"structural":[54],"improvements,":[55],"together":[56],"with":[57],"development":[59],"safe":[61],"efficient":[63],"vehicles":[64],"that":[65,120],"preserve":[66],"mRNA":[67,169],"integrity":[68],"circulation":[70],"allow":[72],"targeted":[73],"intracellular":[74],"delivery,":[75],"have":[76],"paved":[77],"way":[79],"for":[80,99,107,143,171],"mRNA-based":[81],"therapeutics.":[82],"Indeed,":[83],"formulated":[85],"biodegradable":[87],"lipid":[88],"nanoparticles":[89],"currently":[91,147],"being":[92],"tested":[93],"preclinical":[95,162],"clinical":[97],"studies":[98],"multiple":[100],"diseases":[101,146],"including":[102],"cancer":[103],"immunotherapy":[104],"vaccination":[106],"infectious":[108],"diseases.":[109],"An":[110],"emerging":[111],"application":[112],"is":[115],"supplementation":[117],"proteins":[119],"not":[122,126],"expressed":[123],"or":[124],"functional":[127],"regulated":[130],"tissue-specific":[132],"manner.":[133],"This":[134],"so-called":[135],"'protein":[136],"replacement":[137],"therapy'":[138],"could":[139],"represent":[140],"solution":[142],"genetic":[144,174],"metabolic":[145],"lacking":[148],"effective":[149],"treatments.":[150],"Here":[151],"we":[152],"summarise":[153],"this":[154],"drugs":[158],"discuss":[160],"evidence":[163],"supporting":[164],"potential":[166],"liver-mediated":[168],"therapy":[170],"three":[172],"rare":[173],"conditions:":[175],"methylmalonic":[176],"acidaemia,":[177],"acute":[178],"intermittent":[179],"porphyria":[180],"ornithine":[182],"transcarbamylase":[183],"deficiency.":[184]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2917655435","counts_by_year":[{"year":2026,"cited_by_count":12},{"year":2025,"cited_by_count":22},{"year":2024,"cited_by_count":20},{"year":2023,"cited_by_count":24},{"year":2022,"cited_by_count":23},{"year":2021,"cited_by_count":10},{"year":2020,"cited_by_count":11},{"year":2019,"cited_by_count":9}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2019-03-02T00:00:00"}
